These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 12741368

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment.
    Vrouenraets SM, Treskes M, Regez RM, Troost N, Smulders YM, Weigel HM, Frissen PH, Brinkman K.
    Antivir Ther; 2002 Dec; 7(4):239-44. PubMed ID: 12553477
    [Abstract] [Full Text] [Related]

  • 7. Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity.
    Moyle G.
    Clin Ther; 2000 Aug; 22(8):911-36; discussion 898. PubMed ID: 10972629
    [Abstract] [Full Text] [Related]

  • 8. Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy.
    Calza L, Manfredi R, Chiodo F.
    Clin Nutr; 2005 Feb; 24(1):5-15. PubMed ID: 15681097
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Unrecognized near-fatal hyperlactatemia in an HIV-infected infant exposed to nucleoside reverse transcriptase inhibitors.
    Koh MT.
    Int J Infect Dis; 2007 Jan; 11(1):85-6. PubMed ID: 16581278
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.
    Kakuda TN.
    Clin Ther; 2000 Jun; 22(6):685-708. PubMed ID: 10929917
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of the substitution of one nucleoside analogue by one non-nucleoside reverse transcriptase inhibitor over mitochondrial DNA levels.
    De Felipe B, Blanco A, Soriano-Sarabia N, Muñoz-Fernández MA, Genebat M, Vallejo A, Leal M.
    Infection; 2008 Jun; 36(3):266-70. PubMed ID: 18463785
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Understanding the reverse transcriptase inhibitors in HIV.
    Edmonds-Ogbuokiri J.
    Fac Notes (New Orleans La); 1998 Jun; 10(6):13-5. PubMed ID: 11366142
    [Abstract] [Full Text] [Related]

  • 19. Cell culture models for the investigation of NRTI-induced mitochondrial toxicity. Relevance for the prediction of clinical toxicity.
    Höschele D.
    Toxicol In Vitro; 2006 Aug; 20(5):535-46. PubMed ID: 16406476
    [Abstract] [Full Text] [Related]

  • 20. Lactic acidosis in HIV-I infected patients receiving antiretroviral therapy.
    Patel AK, Patel K, Patel J.
    J Assoc Physicians India; 2004 Aug; 52():666-9. PubMed ID: 15847366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.